相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CRISPR/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer
Ailin Chen et al.
CANCER COMMUNICATIONS (2021)
CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells
Shen Li et al.
FEBS OPEN BIO (2021)
Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition
Jun Tian et al.
BREAST CANCER RESEARCH (2021)
A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants
Jiyeon Kweon et al.
ONCOGENE (2020)
Functional characterization of 84 PALB2 variants of uncertain significance
Timothy Wiltshire et al.
GENETICS IN MEDICINE (2020)
Expression and function of FRA1 protein in tumors
Xiaoyan Jiang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency
Kasidet Hiranniramol et al.
BIOINFORMATICS (2020)
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction
Roberto Andorno et al.
TRENDS IN BIOTECHNOLOGY (2020)
PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1
Rimma Belotserkovskaya et al.
NATURE COMMUNICATIONS (2020)
High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
Ana Ricobaraza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Russell T. Walton et al.
SCIENCE (2020)
Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
Dirk Geerts et al.
FRONTIERS IN ONCOLOGY (2020)
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing
Qiang Cheng et al.
NATURE NANOTECHNOLOGY (2020)
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Fathema Uddin et al.
FRONTIERS IN ONCOLOGY (2020)
Impact of CDK4 knock out using CRISPR/Cas9 gene editing technology on breast cancer progression
A. Ahmed et al.
EUROPEAN JOURNAL OF CANCER (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
Karim Shalaby et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
Jialang Zhuang et al.
NUCLEIC ACIDS RESEARCH (2020)
CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
Carolyn Brokowski et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)
Diana Raquel Rodriguez-Rodriguez et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
MEDICAL RESEARCH Molecular envoys aid cancer spread
Anirban Maitra
NATURE (2019)
Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
Danny Wilbie et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Inactivation of APOBEC3G gene in breast cancer cells using the CRISPR/Cas9 system
Rita Mendes de Almeida et al.
ANNALS OF MEDICINE (2019)
Post-translational regulation of ubiquitin signaling
Lei Song et al.
JOURNAL OF CELL BIOLOGY (2019)
Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells
Meng Yang et al.
ONCOTARGETS AND THERAPY (2019)
Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application
Sikandar Hayat Khan
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Emerging Role of Migration and Invasion Enhancer 1 (MIEN1) in Cancer Progression and Metastasis
Prem Prakash Kushwaha et al.
FRONTIERS IN ONCOLOGY (2019)
Engineered materials for in vivo delivery of genome-editing machinery
Sheng Tong et al.
NATURE REVIEWS MATERIALS (2019)
A ligand-based system for receptor-specific delivery of proteins
Mariano Maffei et al.
SCIENTIFIC REPORTS (2019)
BRCA1/2 germline missense mutations: a systematic review
Giovanni Corso et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2018)
Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates
Deborah M. Thurtle-Schmidt et al.
BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION (2018)
The Biology of CRISPR-Cas: Backward and Forward
Frank Hille et al.
CELL (2018)
Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families
Laurent Castera et al.
GENETICS IN MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
D. C. Luther et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
CRISPR deletion of MIEN1 in breast cancer cells
Timothy Van Treuren et al.
PLOS ONE (2018)
Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence
Iain Miller et al.
CELL REPORTS (2018)
CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges
Marta Martinez-Lage et al.
BIOMEDICINES (2018)
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
Monica Alvarez-Fernandez et al.
CELL DEATH AND DIFFERENTIATION (2018)
The interplay between epigenetic changes and the p53 protein in stem cells
Arnold J. Levine et al.
GENES & DEVELOPMENT (2017)
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Chang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Type II CRISPR/Cas9 approach in the oncological therapy
A. Biagioni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination
Weiran Feng et al.
NATURE COMMUNICATIONS (2017)
Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis
Kideok Jin et al.
ONCOTARGET (2017)
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
Ann Lin et al.
ELIFE (2017)
MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells
C. Rattanasinchai et al.
ONCOGENESIS (2017)
First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?
Francoise Baylis et al.
CURRENT GENE THERAPY (2017)
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling
Ke Xu et al.
SCIENTIFIC REPORTS (2017)
Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles
Zeming Chen et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
Implicating Receptor Activator of NF-κB (RANK)/RANK Ligand Signalling in Microglial Responses to Toll-Like Receptor Stimuli
Anton Kichev et al.
DEVELOPMENTAL NEUROSCIENCE (2017)
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee et al.
GENES & DISEASES (2017)
Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels
Michal Sobecki et al.
CANCER RESEARCH (2017)
E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer
Liqiu Liao et al.
CANCER RESEARCH (2017)
Precision genome editing in the CRISPR era
Jayme Salsman et al.
BIOCHEMISTRY AND CELL BIOLOGY (2017)
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells
Emad Heidary Arash et al.
EMBO REPORTS (2017)
CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation
Huajing Wang et al.
CANCER LETTERS (2017)
IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)
Xinxin Long et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Perichromosomal protein Ki67 supports mitotic chromosome architecture
Masatoshi Takagi et al.
GENES TO CELLS (2016)
Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles
Kyung-Rok Yu et al.
HUMAN GENE THERAPY (2016)
CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos
Evguenia Kouranova et al.
HUMAN GENE THERAPY (2016)
Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells
Fei Shen et al.
MOLECULAR CANCER RESEARCH (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
Sara Cuylen et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Engineering Delivery Vehicles for Genome Editing
Christopher E. Nelson et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 7 (2016)
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis
Sudeshna Goswami et al.
ONCOTARGET (2016)
Ki-67 is required for maintenance of cancer stem cells but not cell proliferation
Justin Cidado et al.
ONCOTARGET (2016)
The cell proliferation antigen Ki-67 organises heterochromatin
Michal Sobecki et al.
ELIFE (2016)
Optimization of genome editing through CRISPR-Cas9 engineering
Jian-Hua Zhang et al.
BIOENGINEERED (2016)
Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp
Zhaomin Zhong et al.
SCIENTIFIC REPORTS (2016)
Application of liposomes in medicine and drug delivery
Hadis Daraee et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Liposomes as nanomedical devices
Giuseppina Bozzuto et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression
Marilyne Kpetemey et al.
MOLECULAR CANCER (2015)
Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer
Robert F. Shearer et al.
MOLECULAR CANCER RESEARCH (2015)
Cas9 specifies functional viral targets during CRISPR-Cas adaptation
Robert Heler et al.
NATURE (2015)
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Jiajun Zhu et al.
NATURE (2015)
Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
Daesik Kim et al.
NATURE METHODS (2015)
Precision medicine for metastatic breast cancer-limitations and solutions
Monica Arnedos et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
An updated evolutionary classification of CRISPR-Cas systems
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Rohit Prakash et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Non Viral Vectors in Gene Therapy- An Overview
Murali Ramamoorth et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2015)
Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer
Ines Gruber et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Hiroshi Nishimasu et al.
CELL (2014)
Genome modification by CRISPR/Cas9
Yuanwu Ma et al.
FEBS JOURNAL (2014)
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Sojung Kim et al.
GENOME RESEARCH (2014)
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Ronald G. Crystal
HUMAN GENE THERAPY (2014)
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Carolin Anders et al.
NATURE (2014)
Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity
James K. Nunez et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation
Martin Jinek et al.
SCIENCE (2014)
CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
Pierre Saintigny et al.
CANCER RESEARCH (2013)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Enhanced Efficiency of Human Pluripotent Stem Cell Genome Editing through Replacing TALENs with CRISPRs
Qiurong Ding et al.
CELL STEM CELL (2013)
Breast cancer as a systemic disease: a view of metastasis
A. J. Redig et al.
JOURNAL OF INTERNAL MEDICINE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
CRISPR-Cas systems and RNA-guided interference
Rodolphe Barrangou
WILEY INTERDISCIPLINARY REVIEWS-RNA (2013)
Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
Oscar H. Ocana et al.
CANCER CELL (2012)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Nasim Mavaddat et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
New insights into stability of recombinant adenovirus vector genomes in mammalian cells
Christina Rauschhuber et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair
J. Ross Chapman et al.
JOURNAL OF CELL SCIENCE (2012)
Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli
Ido Yosef et al.
NUCLEIC ACIDS RESEARCH (2012)
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis
M. R. Cronan et al.
ONCOGENE (2012)
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Giedrius Gasiunas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
The ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
M. Angela Nieto
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation
Devaki Bhaya et al.
ANNUAL REVIEW OF GENETICS, VOL 45 (2011)
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer
Michelle W. Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Yadvinder S. Ahi et al.
CURRENT GENE THERAPY (2011)
Prenylated C17orf37 Induces Filopodia Formation to Promote Cell Migration and Metastasis
Subhamoy Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
Jack Cuzick et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza Deltcheva et al.
NATURE (2011)
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
Federico Mingozzi et al.
NATURE REVIEWS GENETICS (2011)
Evolution and classification of the CRISPR-Cas systems
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2011)
RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis
Natsuko Suwaki et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
The chemokine receptor CX(3)CR1 is directly involved in the arrest of breast cancer cells to the skeleton
Whitney L. Jamieson-Gladney et al.
BREAST CANCER RESEARCH (2011)
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer
J. J. Cody et al.
CANCER GENE THERAPY (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
Nancie Petrucelli et al.
GENETICS IN MEDICINE (2010)
Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells
Ke Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
J. R. F. Wilson et al.
JOURNAL OF MEDICAL GENETICS (2010)
BRCA1 and its toolbox for the maintenance of genome integrity
Michael S. Y. Huen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Viral vectors and delivery strategies for CNS gene therapy
Steven J. Gray et al.
THERAPEUTIC DELIVERY (2010)
Gene delivery via DNA incorporation within a biomimetic apatite coating
Linh N. Luong et al.
BIOMATERIALS (2009)
Breast cancer susceptibility: current knowledge and implications for genetic counselling
Tim Ripperger et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
The functional significance behind expressing two IL-8 receptor types on PMN
RoseMarie Stillie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Integration-deficient Lentiviral Vectors: A Slow Coming of Age
Klaus Wanisch et al.
MOLECULAR THERAPY (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells
S. Dasgupta et al.
ONCOGENE (2009)
被撤回的出版物: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (Retracted article. See vol. 298, 2022)
Jianhua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
Zhenhua Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Technology in cancer research and treatment
Boris Rubinsky
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2007)
Similarity trap in protein-protein interactions could be carcinogenic: Simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains
Jin Liu et al.
STRUCTURE (2006)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Chromosome evolution in the Thermotogales:: Large-scale inversions and strain diversification of CRISPR sequences
RT DeBoy et al.
JOURNAL OF BACTERIOLOGY (2006)
CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies
C Pourcel et al.
MICROBIOLOGY-SGM (2005)
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements
FJM Mojica et al.
JOURNAL OF MOLECULAR EVOLUTION (2005)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Binding and recognition in the assembly of an active BRCA1 /BARD1 ubiquitin-ligase complex
PS Brzovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Identification of genes that are associated with DNA repeats in prokaryotes
R Jansen et al.
MOLECULAR MICROBIOLOGY (2002)
Interleukin-8 and human cancer biology
KP Xie
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex
PS Brzovic et al.
NATURE STRUCTURAL BIOLOGY (2001)
Generation and analysis of mice lacking the chemokine fractalkine
DN Cook et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature
K Yamane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The Ki-67 protein: Fascinating forms and an unknown function
E Endl et al.
EXPERIMENTAL CELL RESEARCH (2000)
Biological significance of a family of regularly spaced repeats in the genomes of Archaea, bacteria and mitochondria
FJM Mojica et al.
MOLECULAR MICROBIOLOGY (2000)
分享论文
